| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 6,718,200 | 6,000,500 | 5,405,600 | | Cost of Revenue | 2,131,400 | 1,865,200 | 1,848,700 | | | Gross Profit | 4,586,800 | 4,135,300 | 3,556,900 | | | Operating Expenses | | Research Development | 367,800 | 375,300 | 324,600 | | Selling General and Administrative | 2,625,100 | 2,391,500 | 2,061,700 | | Non Recurring | 34,900 | 19,800 | 52,700 | | Others | 40,000 | 41,400 | 43,600 | | | | Total Operating Expenses | 3,067,800 | 2,828,000 | 2,482,600 | | | | Operating Income or Loss | 1,519,000 | 1,307,300 | 1,074,300 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 61,200 | 62,800 | 29,500 | | Earnings Before Interest And Taxes | 1,580,200 | 1,370,100 | 1,103,800 | | Interest Expense |
-
|
-
|
-
| | Income Before Tax | 1,580,200 | 1,370,100 | 1,103,800 | | Income Tax Expense | 432,400 | 383,400 | 326,100 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 1,147,800 | 986,700 | 777,700 | | | Non-recurring Events | | Discontinued Operations |
-
| 30,700 |
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 1,147,800 | 1,017,400 | 777,700 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $1,147,800 | $1,017,400 | $777,700 |
|
1.52% Nasdaq 0.00%
Income Statement
